ABSTRACT: (261 words)
Since S. caprae was first described by Devriese et al in 1983, based on a strain isolated from 77 goat's milk (reference strain CCM3573) (1), its involvement in veterinary medicine has been 78 well described (2) (3) (4) (5) . This coagulase-negative species is considered as a commensal organism 79 of the skin and mammary gland of goats, but can also cause mastitis. S. caprae is the main 80 species isolated from goat's milk. Surprisingly, this species has been also reported as a human 81 hospital-acquired pathogen, mostly implicated in bone and joint infections (BJI) (6-8). In this 82 context but also in the veterinary environment, it remains difficult to differentiate between 83 contamination, colonization or infection. S. caprae may be misidentified when using old 84 phenotypic methods, leading to an underestimation of its pathogenic role. 85 In this study, we compared three methods for S. caprae identification recovered from BJI or 
. To better understand pathogenicity, we studied the ability to produce a 90 biofilm in vitro. We also investigate by PCR determination the presence of different virulence 91 factors potentially involved in adhesion, biofilm formation and host cell injury: intercellular 92 adhesin regulator icaR, intercellular adhesion operon icaA to icaD, autolysin atlC, fibrinogen 93 binding protein fbe, collagen adhesion cna, lipase lip and an adhesin-like sdrZ (7-11). Finally, 94 we tried to identify a correlation with the clinical features of the patients. 
MATERIAL AND METHODS

98
Study population 99 In this study, all patients with at least one isolate of S. caprae recovered from bone and joint 100 samples between January 2004 and March 2012 at Nantes University hospital were included. period had more than 95% similarity and belonged to the same subgroup.
254
We then built a phylogenetic tree according to the atlC gene sequences using the MEGA6 255 software ( Figure 2 ). We can distinguish four clusters (I to IV Biofilm formation ability was evaluated using the Crystal Violet reference method. Twelve out of thirteen patients were followed up at two years, one was lost from follow-up. 290 Ten patients (83%) were in remission, one patient presented a superinfection with a different 291 staphylococcus species and one presented with S. caprae relapse. For eight patients (61.5%),
292
S. caprae was associated with other bacterial species, whereas for five patients (38.5%) S.
293
caprae was the only species in culture, in one or several samples. For five patients with an osteosynthesis, S. caprae was isolated in more than one sample for 300 three patients. Three patients presented with polymicrobial infection, whereas S. caprae was 301 the only species isolated for 2 patients. 302 Finally, four patients had a prosthesis infection (two hips, two knees). For two patients, S.
303
caprae was the only bacteria present in at least three samples. and their dissemination, as previously described for S. aureus (26, 27) . Nevertheless, the gene, it is tempting to speculate that this marker may constitute a major colonization factor mediating 340 the adhesion of bacteria to bone or medical devices, and constitutes an alternative to screening to 341 determine which population the isolate belongs to. 342
Regarding biofilm production in vitro, no significant difference was observed between H and 343 A isolates, in our experimental conditions. Despite the complexity of evaluating biofilm 344 production due to the great variability in operating conditions (19), the same results were caprae. Other unknown, specific virulence determinants probably play a role in its 405 pathogenicity. This study suggests that biofilm production in S. caprae is a complex 406 mechanism, and is not limited to these few genes. Further studies including whole genome 407 sequencing may provide key arguments to better able to understand its pathogenesis, as 408 recently reported for a multi-resistant S. caprae isolate (11). 
